UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT

PloS one, 2009-09, Vol.4 (9), p.e7258

2009

Volltextzugriff (PDF)

A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells

The Journal of experimental medicine, 2005-05, Vol.201 (9), p.1435-1446

2005

Volltextzugriff (PDF)

Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacology

Nature communications, 2017-11, Vol.8 (1), p.1420-11, Article 1420

2017

Volltextzugriff (PDF)

Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model

PloS one, 2010-03, Vol.5 (3), p.e9430-e9430

2010

Volltextzugriff (PDF)

PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer

Oncotarget, 2018-05, Vol.9 (33), p.23208-23219

2018

Volltextzugriff (PDF)

DUB-3, a Cytokine-inducible Deubiquitinating Enzyme That Blocks Proliferation

The Journal of biological chemistry, 2004-04, Vol.279 (14), p.13993-14000

2004

Volltextzugriff (PDF)

Induction of β3-Integrin Gene Expression by Sustained Activation of the Ras-Regulated Raf–MEK–Extracellular Signal-Regulated Kinase Signaling Pathway

Molecular and Cellular Biology, 2001-05, Vol.21 (9), p.3192-3205

2001

Volltextzugriff (PDF)

In Vivo Assessment of the Next Generation Microtubule-Destabilizing Agent AB8939 in Patient-Derived Xenograft Models of Acute Myeloid Leukemia

Blood, 2019-11, Vol.134 (Supplement_1), p.5142-5142

2019

Volltextzugriff (PDF)

AB8939, a Microtubule-Destabilizing Agent with Potential to Overcome Multidrug Resistance, Is Active across the Range (M0-M7) of Acute Myeloid Leukemia Subtypes

Blood, 2019-11, Vol.134 (Supplement_1), p.5154-5154

2019

Volltextzugriff (PDF)

Anticancer Activity of a Highly Potent Small Molecule Tubulin Polymerization Inhibitor, AB8939

Blood, 2019-11, Vol.134 (Supplement_1), p.2075-2075

2019

Volltextzugriff (PDF)

Mapmodulin: A Possible Modulator of the Interaction of Microtubule-Associated Proteins with Microtubules

Proceedings of the National Academy of Sciences - PNAS, 1997-05, Vol.94 (10), p.5084-5089

1997

Volltextzugriff (PDF)

Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cells

Blood, 2006-08, Vol.108 (3), p.1065-1072

2006

Volltextzugriff (PDF)

Masitinib

PloS one, 2009-09, Vol.4 (9), p.e7258

2009

Volltextzugriff (PDF)

The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawal

Blood, 2001-09, Vol.98 (6), p.1935-1941

2001

Volltextzugriff (PDF)

Mouse B lymphocyte specific endocytosis and recycling of MHC class II molecules

The EMBO journal, 1990-11, Vol.9 (11), p.3489-3496

1990

Volltextzugriff (PDF)

The invariant chain induces compact forms of class II molecules localized in late endosomal compartments

European journal of immunology, 1993-12, Vol.23 (12), p.3158-3166

1993

Volltextzugriff (PDF)

Major histocompatibility complex class II‐restricted presentation of secreted and endoplasmic reticulum resident antigens requires the invariant chains and is sensitive to lysosomotropic agents

European journal of immunology, 1993-12, Vol.23 (12), p.3167-3172

1993

Volltextzugriff (PDF)

Subcellular localization and sorting of MHC class II molecules

Biology of the cell, 1991, Vol.73 (2), p.21a-21a

1991

Volltextzugriff (PDF)

Use of Glucose-6-phosphate Dehydrogenase as a new label for nucleic acid hybridization reactions

Analytical biochemistry, 1989-07, Vol.180 (1), p.50-54

1989

Volltextzugriff (PDF)

Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension

The European respiratory journal, 2017-10, Vol.50 (4), p.1700465-1700465

2017

Volltextzugriff (PDF)

Phenotype and outcome of pulmonary arterial hypertension patients carrying a TBX4 mutation

The European respiratory journal, 2020-05, Vol.55 (5), p.1902340

2020

Volltextzugriff (PDF)

Imaging of pulmonary hypertension in adults: a position paper from the Fleischner Society

The European respiratory journal, 2021-01, Vol.57 (1), p.2004455

2021

Volltextzugriff (PDF)

Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension

American journal of respiratory and critical care medicine, 2021-10, Vol.204 (7), p.842-854

2021

Volltextzugriff (PDF)

Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies

Journal of allergy and clinical immunology, 2017-11, Vol.140 (5), p.1388-1393.e8

2017

Volltextzugriff (PDF)

1 – 25 von 131

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(123)

Publikationsform

Sprache

Englisch
(94)
Französisch
(38)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT

A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells

Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacology

Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model

PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer

DUB-3, a Cytokine-inducible Deubiquitinating Enzyme That Blocks Proliferation

Induction of β3-Integrin Gene Expression by Sustained Activation of the Ras-Regulated Raf–MEK–Extracellular Signal-Regulated Kinase Signaling Pathway

In Vivo Assessment of the Next Generation Microtubule-Destabilizing Agent AB8939 in Patient-Derived Xenograft Models of Acute Myeloid Leukemia

AB8939, a Microtubule-Destabilizing Agent with Potential to Overcome Multidrug Resistance, Is Active across the Range (M0-M7) of Acute Myeloid Leukemia Subtypes

Anticancer Activity of a Highly Potent Small Molecule Tubulin Polymerization Inhibitor, AB8939

Mapmodulin: A Possible Modulator of the Interaction of Microtubule-Associated Proteins with Microtubules

Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cells

Masitinib

The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawal

Mouse B lymphocyte specific endocytosis and recycling of MHC class II molecules

The invariant chain induces compact forms of class II molecules localized in late endosomal compartments

Major histocompatibility complex class II‐restricted presentation of secreted and endoplasmic reticulum resident antigens requires the invariant chains and is sensitive to lysosomotropic agents

Subcellular localization and sorting of MHC class II molecules

Use of Glucose-6-phosphate Dehydrogenase as a new label for nucleic acid hybridization reactions

The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic: A Multinational Consensus Statement From the Fleischner Society

Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension

Phenotype and outcome of pulmonary arterial hypertension patients carrying a TBX4 mutation

Imaging of pulmonary hypertension in adults: a position paper from the Fleischner Society

Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension

Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies

Suchergebnisse filtern